The Immuno-Oncology Translational Network (IOTN) is a consortium to accelerate translation of basic discoveries to clinical applications to improve immunotherapy outcomes for both “hot” and “cold” cancers - and to prevent cancers before they occur. The implementation plan of the IOTN is to focus on leveraging the expertise and resources of a collaborative network to develop improved immunotherapy and immunoprevention approaches - including novel combinations.

      The IOTN is supported by NIH Cancer Moonshot^SM. The Cancer Moonshot^SM aims to accelerate cancer research to make more therapies available to more patients, while also improving our ability to prevent cancer and detect it at an early stage.